Retina Today

Featured

The OCT Issue

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI, and SriniVas R. Sadda, MD, FARVO

Widefield OCT: Extending Structural Imaging into the Periphery

These new tools are improving our view.

Alberto Quarta, MD; Ceren Soylu, MD; and SriniVas R. Sadda, MD, FARVO

Retina Fellows Forum 2026: Pearls for Transitioning to Practice

World-class retina experts shared their tips and tricks to help fellows prepare for the real world ahead.

Prashant D. Tailor, MD, and Alejandro Itzam Marin, MD

The Value of OCTA in Retinal Vascular Disease

Measuring retinal blood flow is easier than ever before, with new tools under investigation to further improve our ability to assess changes in the retinal vasculature.

Sarah Aman, MD; Viet-Hoan Le, PhD; Ruikang K. Wang, PhD; and Amir H. Kashani, MD, PhD

Featured Supplements

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

Understanding Fast Progression in Geographic Atrophy

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

Resources

April 2026

April 2026 | Coding Advisor

Using Category III Codes

Five tips to help improve accuracy, payment, and compliance.

Matthew Baugh, MHA, COT, OCS, OCSR

April 2026 | Up Front

Retina Then and Now: April Spotlight

As part of our 20th anniversary, Retina Today is digging into the archives to reflect on how much the profession has changed.

Jay S. Duker, MD

April 2026 | Global Perspectives

Vigabatrin-Related Retinal Toxicity

Patients taking this medication for epilepsy should be monitored carefully for visual disturbances.

Natalia Londoño De Vivero, MD; Rafael Méndez Marulanda, MD; Daniela Rojas Pérez, MD; Clemencia De Vivero Arciniegas, MD; and Álvaro Mejía Vergara, MD

April 2026 | Special Report

Complex Myopic MHRD: Membranes and Transplants

In the last installment of this three-part series, we describe the latest techniques for managing challenging retinal detachments.

Carlos Mateo, MD, and Anniken Burés-Jelstrup, MD

View Entire Issue

Popular Articles

March 2026 Insert | One To Watch

One to Watch: Archana A. Nair, MD, MS

Archana A. Nair, MD, MS

April 2026 Insert

One to Watch: Samir N. Patel, MD

Samir N. Patel, MD

March 2026 Supplement | Digital Supplement

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

January/February 2026 | Coding Advisor

10 Essential Steps for Accurate Retina Surgery Coding

Keeping these in mind, practices can reduce errors, prevent denials, and maintain accurate billing.

Joy Woodke, COE, OCS, OCSR, and Matthew Baugh, MHA, COT, OCS, OCSR

November/December 2025 Supplement

Preserving Vision in Macular Telangiectasia Type 2

Jay Chhablani, MD, and Lihteh Wu, MD

Stay updated on the most important business acumen in a concise and easy-to-digest format.

View Resource

Recent Supplements

Understanding Fast Progression in Geographic Atrophy

View Insert

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

View Insert

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

View Supplement

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

View Supplement

Featured Authors

Manish Nagpal, MS, FRCS, FASRS

Ahmedabad, India

Racemose Hemangioma An Atlas of Multimodal Imaging in Pediatrics DRIL: A Robust Imaging Biomarker in DME Catching Familial Exudative Vitreoretinopathy Early

Carol L. Shields, MD

Reducing Chemotherapy Duration for High-Risk Retinoblastoma Does Iris Color Matter in Uveal Melanoma? Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma Conditional Survival of Patients With Uveal Melanoma

María H. Berrocal, MD

The New Retina OR: The Latest Vitrectomy Tools Retinectomy for TRD/RRD With PDR and Cataract Your Favorite Secondary IOL Technique Tackle Secondary IOLs With Ease

Eyetube Retina Series

EYETUBE RETINA MEETING COVERAGE

Featured

The OCT Issue

April 2026

Popular Articles

Keep in touch

Retina News

Featured Resource